{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:19:15Z","timestamp":1778077155489,"version":"3.51.4"},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Neuropsychol Soc"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:p>We present the case of a 23-year-old Vietnamese male with a \n2-year history of a psychotic illness marked by prominent negative \nsymptoms, fatuousness and disturbed behavior. Neuroimaging revealed \na prominent vascular flow void affecting the middle and anterior \ncerebral arteries, with associated increased collateral supply \nto the frontal cortex, consistent with Moyamoya disease. \nNeurological examination was unremarkable; however, \nneuropsychological assessment revealed significant executive \ndysfunction, including stimulus-driven behavior. Whilst the \ndiagnosis of schizophrenia and Moyamoya disease may be \ncoincidental, an interaction between the 2 diseases may have \nled to some of the atypical features of this case, including \nprominent executive dysfunction and marked sensitivity to \npsychotropic medication. We discuss the nature of possible \ninteractions between the 2 conditions. This case also highlights \nthe importance of re-evaluating patients with atypical or \ntreatment-resistant psychoses for cerebral pathology. \n(<jats:italic>JINS<\/jats:italic>, 2003, <jats:italic>9<\/jats:italic>, 806\u2013810.)<\/jats:p>","DOI":"10.1017\/s1355617703950132","type":"journal-article","created":{"date-parts":[[2003,8,5]],"date-time":"2003-08-05T18:54:25Z","timestamp":1060109665000},"page":"806-810","source":"Crossref","is-referenced-by-count":31,"title":["Moyamoya disease in a patient with schizophrenia"],"prefix":"10.1017","volume":"9","author":[{"given":"DAN I.","family":"LUBMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHRISTOS","family":"PANTELIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PATRICIA","family":"DESMOND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TINA-MARIE","family":"PROFFITT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DENNIS","family":"VELAKOULIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2003,7,1]]},"container-title":["Journal of the International Neuropsychological Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1355617703950132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T22:25:25Z","timestamp":1554503125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1355617703950132\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S1355617703950132"],"URL":"https:\/\/doi.org\/10.1017\/s1355617703950132","relation":{},"ISSN":["1355-6177","1469-7661"],"issn-type":[{"value":"1355-6177","type":"print"},{"value":"1469-7661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}